Matches in Wikidata for { <http://www.wikidata.org/entity/Q67128896> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q67128896 description "clinical trial" @default.
- Q67128896 description "ensayu clínicu" @default.
- Q67128896 description "klinisch onderzoek" @default.
- Q67128896 description "клінічне випробування" @default.
- Q67128896 name "Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis B" @default.
- Q67128896 name "Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis B" @default.
- Q67128896 type Item @default.
- Q67128896 label "Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis B" @default.
- Q67128896 label "Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis B" @default.
- Q67128896 prefLabel "Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis B" @default.
- Q67128896 prefLabel "Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis B" @default.
- Q67128896 P1050 Q67128896-63836F37-953E-446A-AE21-914C0DDA4E1D @default.
- Q67128896 P1050 Q67128896-8C9D0033-0474-4E27-9559-9439BE3CC20E @default.
- Q67128896 P1050 Q67128896-DEDDA9B4-6F83-4517-AFA6-C41F86A49356 @default.
- Q67128896 P1132 Q67128896-D9F3B685-1707-4F7F-8375-AE36D18EDE85 @default.
- Q67128896 P1476 Q67128896-149C9BCF-86C8-4432-B359-0C17B5CB0BC0 @default.
- Q67128896 P1813 Q67128896-72683EFD-C44A-4357-985F-34E65DEB4A33 @default.
- Q67128896 P2899 Q67128896-DC188543-272A-4F97-B121-231E49AC139C @default.
- Q67128896 P3098 Q67128896-D805018E-72DE-4F8D-84AE-EB8D787385E5 @default.
- Q67128896 P31 Q67128896-BB94ABB6-ECF9-4989-AF80-658424B80898 @default.
- Q67128896 P4135 Q67128896-6C7FC233-9138-43BD-8A2E-ACB194F51639 @default.
- Q67128896 P4844 Q67128896-097A1479-D23E-45F1-B34C-16B3CCBEED16 @default.
- Q67128896 P580 Q67128896-DAAB96A3-2137-4A9F-9A9D-9645E3E40218 @default.
- Q67128896 P582 Q67128896-D1538DE0-7C33-4FAC-9A8D-3775968019DF @default.
- Q67128896 P6099 Q67128896-0EF07925-E613-485A-B451-4399F62138E4 @default.
- Q67128896 P8363 Q67128896-8643FC9B-82B7-473C-B1DD-E60659F39A4A @default.
- Q67128896 P1050 Q131742 @default.
- Q67128896 P1050 Q157661 @default.
- Q67128896 P1050 Q6853 @default.
- Q67128896 P1132 "+463" @default.
- Q67128896 P1476 "Combination Treatment of Polyethylene Glycol Thymosin alpha1 (PEG-Tα1) and Adefovir for Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B: A Multi-center Randomized, Double-blind, Parallel-controlled Phase Ⅲ Trial" @default.
- Q67128896 P1813 "PEG-Tα1" @default.
- Q67128896 P2899 "+18" @default.
- Q67128896 P3098 "NCT02366247" @default.
- Q67128896 P31 Q30612 @default.
- Q67128896 P4135 "+65" @default.
- Q67128896 P4844 Q20817234 @default.
- Q67128896 P580 "2013-08-01T00:00:00Z" @default.
- Q67128896 P582 "2015-12-01T00:00:00Z" @default.
- Q67128896 P6099 Q42824827 @default.
- Q67128896 P8363 Q78089383 @default.